Medical Advocates

HIV Infection/Disease
 
Hypertension


Hypertension
Portal Hypertension
Pulmonary Arterial Hypertension




 



 

HIV Vascular Main Page Main New/Newsworthy  Home Page      

Last Update: December 11, 2017
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader.

Hypertension   
       

         Journal Papers, Abstracts, and Comment

 

Human Immunodeficiency Virus Infection And Hypertension. Is There A Connection?
Sanidas E, Papadopoulos DP, Velliou M, et al ;

Am J Hypertens
. 2017 Dec 6.
Abstract

Integrating cardiovascular diseases, hypertension, and diabetes with HIV services: a systematic review.
Haldane V, Legido-Quigley H, Chuah FLH, et al
AIDS Care. 2017 Jul 5:1-13.
Abstract

Hypertension in HIV: Management and Treatment.
Ucciferri C, Falasca K, Vecchiet J.
AIDS Rev. 2017 May 23;19(2).
.

Abstract

Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis.
Nduka CU, Stranges S, Sarki AM, et al

J Hum Hypertens
. 2015 Oct 8
Abstract

Burden, Determinants, and Pharmacological Management of Hypertension in HIV-Positive Patients and Populations: A Systematic Narrative Review.
Nguyen KA, Peer N, Mills EJ, Kengne AP.

AIDS Rev
. 2015 Apr-Jun;17(2):83-95..
Abstract

Prevalence, Awareness, Treatment, and Control Rate of Hypertension in HIV-Infected Patients: The HIV-HY Study.
De Socio GV, Ricci E, Maggi P, et al
Am J Hypertens. 2014 Feb;27(2):222-8
Abstract

FULL-TEXT PDF ARTICLE
Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study.
Kotwani P, Kwarisiima D, Clark TD,  et al

BMC Public Health
. 2013 Dec 9;13(1):1151
Paper

Arterial hypertension and cardiovascular risk in HIV-infected patients.
Calò LA, Caielli P, Maiolino G, Rossi G.
J Cardiovasc Med (Hagerstown). 2013 Jun 26.
Abstract

Correlates of Hypertension in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy
Krauskopf K, Natta ML, Danis RP, et al
J Int Assoc Provid AIDS Care. 2013 Jun 13
Abstract

Low Nadir CD4 Cell Count Predicts Sustained Hypertension in HIV-Infected Individuals.
Manner IW, Trøseid M, Oektedalen O,  et al

J Clin Hypertens
(Greenwich)
2013 Feb;15(2):101-6.
Abstract

Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study.
Manner IW, Baekken M, Oektedalen O, Os I.
Blood Press
. 2012 May 8..
Abstract

Antihypertensive Drugs in Patients Treated with Antiretrovirals (May).
Peyriere H, Eiden C, Macia JC, Reynes J.
 
Ann Pharmacother
. 2012 May 1.
Abstract

Prevalence and risk factors associated with pulmonary hypertension in hiv-infected patients on regular follow-up.[Spain]
Quezada M, Martin-Carbonero L, Soriano V,  et al

AIDS
. 2012 Apr 21..
Abstract

Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
Vecchiet J, Ucciferri C, Falasca K, et al

Antivir Ther
. 2011;16(5):639-45.
Abstract

Hypertension and Isolated Office Hypertension in HIV-Infected Patients Determined By Ambulatory Blood Pressure Monitoring: Prevalence and Risk Factors.
Ji B, Fx Z,  Fj PP,  et al

J Acquir Immune Defic Syndr
. 2011 Jun 7.
Abstract
 

 

          Conference Reports, Abstracts, and Posters

 
Incidence and predictors of hypertension in HIV infected patients: an Asian perspective
V. Sapsirisava, D. Trachunthong, S.J. Kerr, et al
(XX International AIDS Conference)
Abstract
 

Portal Hypertension
       

         Journal Papers, Abstracts, and Commentaries

 
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.
Yajima K, Uehira T, Otera H, et al
J Infect Chemother. 2014 Jul 14.
.
Abstract

Clinical factors that predict non-cirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.
Parikh ND, Martel-Laferriere V, Kushner T,  et al
J Infect Dis. 2013 Aug 2.
Abstract

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.
Schouten JN, Van der Ende ME, Koëter T,  et al

Aliment Pharmacol Ther
. 2012 Sep 13.
Abstract

Non-cirrhotic portal hypertension in HIV mono-infected patients.
Jackson BD, Doyle JS, Hoy JF, et al
J Gastroenterol Hepatol. 2012 Apr 13..
Abstract

Noncirrhotic portal hypertension in HIV infection.
Vispo E, Morello J, Rodriguez-Novoa S, Soriano V.

Curr Opin Infect Dis
. 2010 Dec 13
Abstract

          Conference Reports, Abstracts, and Posters

  Non-cirrhotic portal hypertension in HIV-positive individuals: should we still worry about previous DDI exposure?
M. Cevik, G. Jagjit Singh, A. Scourfield, M. Nelson.
(XIX International AIDS Conference)
Abstract

Pulmonary Arterial Hypertension
       

         Journal Papers, Abstracts, and Comment

 

Pulmonary arterial hypertension associated with human immunodeficiency virus infection: 4 cases analysis.
Pousada G, Baloira A, Castro-Añón O, Valverde D.

Med Clin (
Barc)
. 2016 Feb 17.
Abstract

Pharmacological treatment of HIV-associated pulmonary hypertension.
Chinello P, Petrosillo N.
Expert Rev Clin Pharmacol. 2016 Feb 10.
Abstract

Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States.
Henriques-Forsythe M, Annangi S, Farber HW.  

Pulm Circ
. 2015 Sep;5(3):506-12
Abstract

HIV-associated pulmonary arterial hypertension: from bedside to the future.
Correale M, Palmiotti GA, Lo Storto MM, et al
Eur J Clin Invest. 2015 Feb 26
Abstract

Efficacy of sildenafil in HIV-related pulmonary arterial hypertension.
Pergola V, Caruso C, Gnarini R, et al
J Cardiovasc Med (Hagerstown). 2015 Jan;16 Suppl 14:S136-S137.
Abstract

Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension.
Frustaci A, Petrosillo N, Vizza D,  et al
AIDS. 2014 Aug 19
Abstract

Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients.
Ten Freyhaus H, Vogel D, Lehmann C,  et al
Infection. 2014 Mar 12.

Abstract

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.
Parikh RV, Scherzer R, Nitta EM,  et al  

AIDS
. 2014 Jan 23
Abstract

Inflammatory Mechanisms in HIV-Associated Pulmonary Arterial Hypertension.
Tcherakian C, Couderc LJ, Humbert M,  et al

Semin Respir Crit Care Med
. 2013 Oct;34(5):645-53

Abstract

FULL-TEXT ARTICLE
Human Immunodeficiency Virus and Pulmonary Arterial Hypertension.
Mirrakhimov AE, Ali AM, Barbaryan A, Prueksaritanond S.

ISRN Cardio
l
. 2013 Aug 21;2013:903454.
Paper

HIV-related pulmonary arterial hypertension
Savale L, Lador F, Jais X, et al
Rev Mal Respir. 2012 Apr;29(4):491-500.
Abstract

HIV infection and pulmonary arterial hypertension.
Cicalini S, Chinello P, Petrosillo N.
Expert Rev Respir Med. 2011 Apr;5(2):257-266
Abstract

Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective.
Almodovar S, Cicalini S, Petrosillo N, Flores SC.

Chest
. 2010 Jun;137(6 Suppl):6S-12S.
Abstract

HIV and pulmonary arterial hypertension: a systematic review.
Janda S, Quon BS, Swiston J.

HIV Med
. 2010 Apr 7.
Abstract

HIV-associated pulmonary arterial hypertension: survival and prognostic factorsin the modern therapeutic era.
Degano B, Guillaume M, Savale L, et al

AIDS
. 2010 Jan 2;24(1):67-75.
Abstract

 


HIV Vascular Main Page Main New/Newsworthy  Home Page      

HIV-Related Vascular Disorders